down arrow

Alivus Life

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
948.35
6.4 (0.68%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 46.14 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

946.00988.00

52 Week

743.601,335.00
Valuation
Technical
Day's Volume

CASH

46.14 k (-12.02%) Volume

Shareholding (Dec 2024)

FII

6.74%

Held by 66 FIIs

DII

4.86%

Held by 7 DIIs

Promoter

75.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROE of 19.11%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Poor long term growth as Operating profit has grown by an annual rate -2.28% of over the last 5 years

 
4

Flat results in Dec 24

5

Technical trend is Sideways signifying no clear price momentum

6

With ROE of 17.4, it has a Fair valuation with a 4.5 Price to Book Value

7

Majority shareholders : Promoters

 
8

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 11,621 Cr (Mid Cap)

stock-summary
P/E

26.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

17.40%

stock-summary
Price to Book

4.55

Revenue and Profits (1 Year):
Net Sales:
642 Cr
(Quarterly Results - Dec 2024)
Net Profit:
137 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-20.97%
0%
-20.97%
1 Year
16.19%
0%
16.19%
2 Years
135.73%
4.16%
139.89%
3 Years
91.33%
12.49%
103.82%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 22.5 per share ex-dividend date: Oct-17-2023

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
3.08%
EBIT Growth (5y)
-2.28%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.17
Tax Ratio
25.46%
Dividend Payout Ratio
58.54%
Pledged Shares
0
Institutional Holding
11.60%
ROCE (avg)
39.66%
ROE (avg)
19.11%
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
33
Price to Book Value
4.55
EV to EBIT
19.62
EV to EBITDA
17.76
EV to Capital Employed
5.27
EV to Sales
4.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
26.12%
ROE (Latest)
17.40%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 11 Schemes (3.23%)

FIIs

Held by 66 FIIs (6.74%)

Promoter with highest holding

Nirma Limited (75.0%)

Highest Public shareholder

Polar Capital Funds Plc - Healthcare Opportunities (2.79%)

Individual Investors Holdings

10.99%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 26.63% vs -13.89% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 43.68% vs -14.50% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "641.84",
          "val2": "506.88",
          "chgp": "26.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "190.30",
          "val2": "134.36",
          "chgp": "41.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.46",
          "val2": "0.34",
          "chgp": "35.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "136.96",
          "val2": "95.32",
          "chgp": "43.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.65%",
          "val2": "26.51%",
          "chgp": "3.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -6.67% vs 17.48% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -18.64% vs 17.89% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,095.50",
          "val2": "1,173.81",
          "chgp": "-6.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "293.85",
          "val2": "360.24",
          "chgp": "-18.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.80",
          "chgp": "-12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "206.80",
          "val2": "254.19",
          "chgp": "-18.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.82%",
          "val2": "30.69%",
          "chgp": "-3.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -0.53% vs 13.42% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -7.83% vs 16.33% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,737.34",
          "val2": "1,746.61",
          "chgp": "-0.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "484.15",
          "val2": "532.79",
          "chgp": "-9.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.16",
          "val2": "1.19",
          "chgp": "-2.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "343.76",
          "val2": "372.96",
          "chgp": "-7.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.87%",
          "val2": "30.50%",
          "chgp": "-2.63%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 5.64% vs 1.79% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 0.84% vs 11.52% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,283.21",
          "val2": "2,161.22",
          "chgp": "5.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "674.24",
          "val2": "642.29",
          "chgp": "4.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.55",
          "val2": "0.55",
          "chgp": "181.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "470.89",
          "val2": "466.96",
          "chgp": "0.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.53%",
          "val2": "29.72%",
          "chgp": "-0.19%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
641.84
506.88
26.63%
Operating Profit (PBDIT) excl Other Income
190.30
134.36
41.63%
Interest
0.46
0.34
35.29%
Exceptional Items
0.00
0.00
Standalone Net Profit
136.96
95.32
43.68%
Operating Profit Margin (Excl OI)
29.65%
26.51%
3.14%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 26.63% vs -13.89% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 43.68% vs -14.50% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,095.50
1,173.81
-6.67%
Operating Profit (PBDIT) excl Other Income
293.85
360.24
-18.43%
Interest
0.70
0.80
-12.50%
Exceptional Items
0.00
0.00
Standalone Net Profit
206.80
254.19
-18.64%
Operating Profit Margin (Excl OI)
26.82%
30.69%
-3.87%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -6.67% vs 17.48% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -18.64% vs 17.89% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,737.34
1,746.61
-0.53%
Operating Profit (PBDIT) excl Other Income
484.15
532.79
-9.13%
Interest
1.16
1.19
-2.52%
Exceptional Items
0.00
0.00
Standalone Net Profit
343.76
372.96
-7.83%
Operating Profit Margin (Excl OI)
27.87%
30.50%
-2.63%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -0.53% vs 13.42% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -7.83% vs 16.33% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
2,283.21
2,161.22
5.64%
Operating Profit (PBDIT) excl Other Income
674.24
642.29
4.97%
Interest
1.55
0.55
181.82%
Exceptional Items
0.00
0.00
Standalone Net Profit
470.89
466.96
0.84%
Operating Profit Margin (Excl OI)
29.53%
29.72%
-0.19%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 5.64% vs 1.79% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 0.84% vs 11.52% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Alivus Life Sciences Ltd stock-summary
stock-summary
Alivus Life Sciences Ltd
Mid Cap
Pharmaceuticals & Drugs
Glenmark Life Sciences Limited was incorporated as `Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune. Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to `Glenmark Life Sciences Private Limited' dated 10 August 2018.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."